Relationships between Serum Adiponectin with Metabolic Syndrome and Components of Metabolic Syndrome in Non-Diabetic Koreans: ARIRANG Study

被引:29
|
作者
Koh, Sang-Baek [2 ,3 ]
Yoon, Junghan [1 ,3 ]
Kim, Jang-Young [1 ,3 ]
Yoo, Byung-Su [1 ,3 ]
Lee, Seung-Hwan [1 ,3 ]
Park, Jong-Ku [2 ,3 ]
Choe, Kyung-Hoon [1 ]
机构
[1] Yonsei Univ, Dept Cardiol, Wonju Coll Med, Wonju 220701, South Korea
[2] Yonsei Univ, Dept Prevent Med, Wonju Coll Med, Wonju 220701, South Korea
[3] Yonsei Univ, Inst Genom Cohort, Wonju 220701, South Korea
关键词
Adiponectin; metabolic syndrome; Korea; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE SYNDROME; PLASMA ADIPONECTIN; CARDIOVASCULAR-DISEASE; RISK; MORTALITY; ASSOCIATION; PREDICTOR; PROTEIN; MEN;
D O I
10.3349/ymj.2011.52.2.234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Growing evidence suggests that hypoadiponectinemia may play a significant role in the development of metabolic syndrome (MetS). Therefore, the relationships between serum adiponectin with MetS and components of MetS were investigated in non-diabetic samples of drawn from the Koreans general population. Materials and Methods: We performed a cross-sectional study in samples of older Koreans (age > 40 years) including 2,471 men and 3,463 women. MetS was defined according to the Asian modified criteria of the National Cholesterol Education Program Adult Treatment Panel UT report. Serum adiponectin concentrations were measured by radioimmunoassay. Results: The median adiponectin level in MetS was significantly lower than that in non-MetS subjects in men (6.00 vs. 8.00 mu g/mL, p < 0.001) and women (10.12 vs. 11.74 mu g/mL, p < 0.001). Adiponectin concentration was negatively correlated with waist circumference and levels of triglyceride, C-reactive protein (CRP), fasting glucose, and insulin, and positively correlated with high-density lipoprotein and age in both genders (p < 0.001). In a multivariate regression model after adjustment for age, body mass index, smoking, CRP, and lipid profiles, the odds ratio of MetS comparing extreme quartiles of adiponectin distribution was 0.32 [95% confidence interval (CI), 0.20 to 0.50] in men and 0.57 (95% CI, 0.43 to 0.76) in women. Conclusion: Adiponectin levels are independently associated with the phenotype of MetS, as well as components of MetS in the non-diabetic Korean general population.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 50 条
  • [31] Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population
    Masulli, Maria
    Riccardi, Gabriele
    Galasso, Rocco
    Vaccaro, Olga
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (05) : 364 - 370
  • [32] Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome
    Chen, Shu-Ju
    Yen, Chi-Hua
    Huang, Yi-Chia
    Lee, Bor-Jen
    Hsia, Simon
    Lin, Ping-Ting
    PLOS ONE, 2012, 7 (09):
  • [33] Association between Microalbuminuria and Metabolic syndrome in Korean obese non-diabetic children
    Lee, Seon Yeong
    Sung, Eun Ju
    Shin, Bo Moon
    Yoon, Do Kyung
    Kim, Sun Mee
    Cho, Kyung Hwan
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S88 - S88
  • [34] The prevalence of metabolic syndrome components in non-diabetic patients admitted with acute coronary syndrome: a prospective study in males versus females
    Gehani, A. A.
    Al-Aqeedi, Rafid
    Khaled, Waleed
    Dabdoob, Wafer
    Benner, AbdulBari
    CIRCULATION, 2012, 125 (19) : E905 - E905
  • [35] Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men
    Gannage-Yared, Marie-Helene
    Khalife, Simon
    Semaan, Michelle
    Fares, Florence
    Jambart, Selim
    Halaby, Georges
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (01) : 167 - 176
  • [36] Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome
    Bahia, Luciana
    Aguiar, Luiz Guilherme K.
    Villela, Nivaldo
    Bottino, Daniel
    Godoy-Matos, Amelio F.
    Geloneze, Bruno
    Tambascia, Marcos
    Bouskela, Eliete
    ATHEROSCLEROSIS, 2007, 195 (01) : 138 - 146
  • [37] Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome
    Kim, SG
    Ryu, OH
    Kim, HY
    Lee, KW
    Seo, JA
    Kim, NH
    Choi, KM
    Lee, J
    Baik, SH
    Choi, DS
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (03) : 433 - 440
  • [38] Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome
    de las Heras, Natalia
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (01): : 35 - 36
  • [39] Visfatin and Adiponectin Have an Opposite Correlation with Inflammation and Metabolic Syndrome in Non-Diabetic Obese Indonesian Men
    Meiliana, Anna
    Lawrence, Gatot Susilo
    Patellongi, Ilhamjaya
    Wijaya, Andi
    As'ad, Suryani
    INDONESIAN BIOMEDICAL JOURNAL, 2009, 1 (03): : 81 - 87
  • [40] Metabolic syndrome in non-diabetic Europeans:: Relation to cardiovascular mortality
    Pyorala, K.
    Qiao, Q.
    Gao, W. G.
    Balkau, B.
    Borch-Johnsen, K.
    Alberti, K. G. M. M.
    Tuomilehto, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 154 - 154